US Patent 10039779 | Patents | Expiry | Expiration | Dates

GILEAD SCIENCES INC

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United States Flag United States

Post An Enquiry

Virtual Booth

LEDIPASVIR; SOFOSBUVIR

Supporting Information : Click here to upload a PDF

US Patent Number

10039779

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2034-01-30

Patent Use Code

U-2370

Delist Requested

Application Number

205834

Patent Use Description

Product Number

1

GILEAD SCIENCES INC

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United States Flag United States

Post An Enquiry

Virtual Booth

LEDIPASVIR; SOFOSBUVIR

Supporting Information : Click here to upload a PDF

US Patent Number

10039779

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2034-01-30

Patent Use Code

U-1470

Delist Requested

Application Number

205834

Patent Use Description

FOR THE TREATMENT OF HEPATITIS C

Product Number

2

GILEAD SCIENCES INC

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United States Flag United States

Post An Enquiry

Virtual Booth

LEDIPASVIR; SOFOSBUVIR

Supporting Information : Click here to upload a PDF

US Patent Number

10039779

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2034-01-30

Patent Use Code

U-2369

Delist Requested

Application Number

205834

Patent Use Description

Product Number

Find

Information, Expiry & Status of FDA Orange Book Patents covering 10039779

Gilead Sciences

GILEAD SCIENCES INC

LEDIPASVIR; SOFOSBUVIR

10039779

Y

Y

2034-01-30

U-2370

205834

1

GILEAD SCIENCES INC

LEDIPASVIR; SOFOSBUVIR

10039779

Y

Y

2034-01-30

U-1470

205834

FOR THE TREATMENT OF HEPATITIS C

2

GILEAD SCIENCES INC

LEDIPASVIR; SOFOSBUVIR

10039779

Y

Y

2034-01-30

U-2369

205834

1